A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma
抗 PD-1 卡瑞利珠单抗与 VEGFR2 抑制剂阿帕替尼新辅助联合治疗局部晚期可切除口腔鳞状细胞癌的初步研究
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-022-33080-8
Wu-Tong Ju, Rong-Hui Xia, Dong-Wang Zhu, Sheng-Jin Dou, Guo-Pei Zhu, Min-Jun Dong, Li-Zhen Wang, Qi Sun, Tong-Chao Zhao, Zhi-Hang Zhou, Si-Yuan Liang, Ying-Ying Huang, Yong Tang, Si-Cheng Wu, Jing Xia, Shi-Qing Chen, Yue-Zong Bai, Jiang Li, Qi Zhu, Lai-Ping Zhong